Literature DB >> 7534226

Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency.

D N Sheppard1, L S Ostedgaard, M C Winter, M J Welsh.   

Abstract

Variability in the severity of cystic fibrosis (CF) is in part due to specific mutations in the CF transmembrane conductance regulator (CFTR) gene. To understand better how mutations in CFTR disrupt Cl- channel function and to learn about the relationship between genotype and phenotype, we studied two CF mutants, A455E and P574H, that are associated with pancreatic sufficiency. A455E and P574H are located close to conserved ATP binding motifs in CFTR. Both mutants generated cAMP-stimulated apical membrane Cl- currents in heterologous epithelial cells, but current magnitudes were reduced compared with wild-type. Patch-clamp analysis revealed that both mutants had normal conductive properties and regulation by phosphorylation and nucleotides. These mutants had normal or increased Cl- channel activity: A455E had an open-state probability (Po) similar to wild-type, and P574H had an increased Po because bursts of activity were prolonged. However, both mutants produced less mature glycosylated protein, although levels were greater than observed with the delta F508 mutant. These changes in channel activity and processing provide a quantitative explanation for the reduced apical Cl- current. These data also dissociate structural requirements for channel function from features that determine processing. Finally, the results suggest that the residual function associated with these two mutants is sufficient to confer a milder clinical phenotype and infer approaches to developing treatments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534226      PMCID: PMC398160          DOI: 10.1002/j.1460-2075.1995.tb07069.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

Review 1.  The cystic fibrosis transmembrane conductance regulator.

Authors:  J R Riordan
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

2.  Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

Authors:  W Dalemans; P Barbry; G Champigny; S Jallat; K Dott; D Dreyer; R G Crystal; A Pavirani; J P Lecocq; M Lazdunski
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

3.  Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.

Authors:  D N Sheppard; D P Rich; L S Ostedgaard; R J Gregory; A E Smith; M J Welsh
Journal:  Nature       Date:  1993-03-11       Impact factor: 49.962

4.  Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains.

Authors:  M P Anderson; M J Welsh
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

5.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

Authors:  G M Denning; M P Anderson; J F Amara; J Marshall; A E Smith; M J Welsh
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

6.  Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis.

Authors:  R Rozen; M De Braekeleer; J Daigneault; L Ferreira-Rajabi; M Gerdes; L Lamoureux; G Aubin; F Simard; T M Fujiwara; K Morgan
Journal:  Am J Med Genet       Date:  1992-02-01

7.  Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

Authors:  N Kartner; O Augustinas; T J Jensen; A L Naismith; J R Riordan
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

8.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

Review 9.  Cystic fibrosis: molecular biology and therapeutic implications.

Authors:  F S Collins
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

10.  Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia.

Authors:  G M Denning; L S Ostedgaard; M J Welsh
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  27 in total

1.  A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.

Authors:  Qian Dong; Christoph O Randak; Michael J Welsh
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

2.  Ion Transport in Health and Disease. Symposium proceedings. University College Cork, 19-20 September 1995.

Authors: 
Journal:  J Physiol       Date:  1995-11       Impact factor: 5.182

3.  Orphan missense mutations in the cystic fibrosis transmembrane conductance regulator: A three-step biological approach to establishing a correlation between genotype and phenotype.

Authors:  Fleur Fresquet; Romain Clement; Caroline Norez; Adélaïde Sterlin; Patricia Melin; Frédéric Becq; Alain Kitzis; Vincent Thoreau; Frédéric Bilan
Journal:  J Mol Diagn       Date:  2011-06-25       Impact factor: 5.568

4.  CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR.

Authors:  Yiting Wang; Jia Liu; Avgi Loizidou; Luc A Bugeja; Ross Warner; Bethan R Hawley; Zhiwei Cai; Ashley M Toye; David N Sheppard; Hongyu Li
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.

Authors:  Zhiwei Cai; Timea Palmai-Pallag; Pissared Khuituan; Michael J Mutolo; Clément Boinot; Beihui Liu; Toby S Scott-Ward; Isabelle Callebaut; Ann Harris; David N Sheppard
Journal:  J Physiol       Date:  2015-04-09       Impact factor: 5.182

6.  Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.

Authors:  S B Fulmer; E M Schwiebert; M M Morales; W B Guggino; G R Cutting
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

7.  Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia.

Authors:  Lynda S Ostedgaard; Christoph Randak; Tatiana Rokhlina; Philip Karp; Daniel Vermeer; Katherine J Ashbourne Excoffon; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

8.  Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.

Authors:  Jeng-Haur Chen; Zhiwei Cai; David N Sheppard
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

9.  Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.

Authors:  Estelle Cormet-Boyaka; Michael Jablonsky; Anjaparavanda P Naren; Patricia L Jackson; Donald D Muccio; Kevin L Kirk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

10.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.